Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Classement en actions #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Prix de l'action
$36.75
Dernière synchronisation: 2026-08-27
Capitalisation boursière
$1.63B
Changement (1 jour)
-0.78%
Changement (1 an)
-
Pays
US
Échange Avalyn Pharma Inc. Common Stock (AVLN)

Catégorie

Historique du prix de l'action pour Avalyn Pharma Inc. Common Stock (AVLN)
Prix de clôture le plus élevé : $36.94 le 2026-08-01

Prix de clôture le plus bas : $29.49 le 2026-04-01
Historique du prix de l'action de Avalyn Pharma Inc. Common Stock de 2026 à 2026
Performance annuelle du prix de l'action
Année Performance
Pas assez de données pour les dates fournies.
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$762.91 7.41%
CH